Ampio Pharmaceuticals Depreciation & Amortization 2011-2026 | AMPE

Annual Depreciation & Amortization Ampio Pharmaceuticals

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
122 K	1.05 M	1.09 M	1.18 M	1.27 M	1.28 M	1.21 M	1.21 M	825 K	341 K	138 K	62.4 K	42.6 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.28 M	42.6 K	756 K

Quarterly Depreciation & Amortization Ampio Pharmaceuticals

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	122 K	-	347 K	256 K	262 K	-	831 K	568 K	294 K	-	885 K	591 K	295 K	-	975 K	736 K	365 K	-	968 K	621 K	301 K	-	911 K	607 K	304 K	-	917 K	611 K	306 K	-	618 K	412 K	206 K	-	210 K	83.1 K	41.2 K	-	97.3 K	57.8 K	18.5 K	-	46.8 K	31.2 K	15.6 K	-	27 K	11.4 K	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
975 K	11.4 K	387 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Apellis Pharmaceuticals APLS	1.56 M	$ 20.7	-1.24 %	$ 2.61 B	USA
Aptorum Group Limited APM	1.13 M	$ 0.84	7.59 %	$ 4.58 M	China
Axsome Therapeutics AXSM	503 K	$ 166.38	1.52 %	$ 8.28 B	USA
AbCellera Biologics ABCL	18.4 M	$ 3.82	5.82 %	$ 1.14 B	Canada
Capricor Therapeutics CAPR	1.07 M	$ 26.86	-3.83 %	$ 719 M	USA
Codexis CDXS	4.95 M	$ 1.02	0.99 %	$ 74.9 M	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
CNS Pharmaceuticals CNSP	3.31 K	$ 3.13	-0.95 %	$ 1.2 M	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Collegium Pharmaceutical COLL	4.18 M	$ 41.6	-0.17 %	$ 1.32 B	USA
Corcept Therapeutics Incorporated CORT	1.15 M	$ 35.97	0.76 %	$ 3.74 B	USA
Catalyst Pharmaceuticals CPRX	375 K	$ 23.88	3.47 %	$ 2.92 B	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Corbus Pharmaceuticals Holdings CRBP	641 K	$ 8.35	-2.57 %	$ 36.1 M	USA
Curis CRIS	203 K	$ 1.08	-5.26 %	$ 6.81 M	USA
Crinetics Pharmaceuticals CRNX	3.9 M	$ 40.68	-1.02 %	$ 3.83 B	USA
Corvus Pharmaceuticals CRVS	151 K	$ 17.89	-2.03 %	$ 859 M	USA
Champions Oncology CSBR	1.6 M	$ 6.07	2.71 %	$ 82.9 M	USA
Citius Pharmaceuticals CTXR	1.43 K	$ 0.72	-2.3 %	$ 4.84 M	USA
CEL-SCI Corporation CVM	2.14 M	$ 3.83	-10.09 %	$ 244 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Daré Bioscience DARE	42.3 K	$ 1.61	-5.29 %	$ 13.7 M	USA
DBV Technologies S.A. DBVT	2.72 M	$ 23.25	10.77 %	$ 2.26 B	France
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Precision BioSciences DTIL	6.82 M	$ 4.33	3.1 %	$ 16.6 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	13.6 M	$ 3.34	0.3 %	$ 1.2 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Editas Medicine EDIT	5.81 M	$ 2.15	-2.27 %	$ 177 M	USA
Edesa Biotech EDSA	186 K	$ 2.28	3.64 %	$ 7.29 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Agios Pharmaceuticals AGIO	5.2 M	$ 29.2	-3.41 %	$ 1.69 B	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Equillium EQ	126 K	$ 1.92	5.49 %	$ 66.7 M	USA